Pharma manufacturer's tax appeal dismissed due to discrepancies in income calculation

The courts upheld the rejection of book results for the assessment years 2007-08 and 2008-09 for a pharmaceutical drug manufacturer. Additional income of Rs. 88.47 lakhs was added due to discrepancies in raw material consumption and unaccounted purchases. The CIT(Appeals) and Tribunal applied a 35% GP ratio on the excess consumption and excess sales, aligning with previous rulings and factual evidence. The courts clarified the difference between raw material consumption and sales, affirming the taxation of income based on profit elements. The Tax Appeals were dismissed, confirming the decisions of the lower authorities.

---

---

Issues:
1. Assessment of appropriate additions to the income of the assessee after rejection of book results for assessment years 2007-08 and 2008-09.

Analysis:
1. The assessing officer found discrepancies in the recording of raw material consumption by the pharmaceutical drug manufacturer, leading to the estimation of excess raw material consumption at 46.05%. Additionally, unaccounted purchases were noted, resulting in the addition of Rs. 88.47 lakhs to the assessee's income. The CIT(Appeals) upheld the rejection of book results and limited the additions by applying a 35% GP ratio on the extra consumption taken at 20% of the turnover. This decision was based on previous court rulings emphasizing the taxation of net profit rather than entire sales. The Tribunal confirmed the CIT(Appeals) decision, rationalizing the estimation of profit element at 36% of the extra consumption.

2. The assessing officer's approach of adding 40% of the total turnover as income due to excess production and sales was challenged by the CIT(Appeals) and the Tribunal. They reduced the excess sales to 20% of turnover and applied a 35% GP rate based on the average of three years. This decision aligned with precedents like Commissioner of Income-tax vs. President Industries and Commissioner of Income-tax vs. Gurubachhan Singh J. Juneja. The courts deemed this exercise as factual and evidence-based, dismissing the Revenue's argument to add the entire excess consumption to income without evidence of unaccounted expenditures related to production.

3. The assessing officer's confusion between excess raw material consumption and unaccounted sale of finished products was clarified by the courts. They highlighted that excess raw material consumption does not directly equate to excess sales, as manufacturing processes involve various costs beyond raw materials. The CIT(Appeals) correctly attempted to tax the income arising from unaccounted raw material consumption by applying a GP rate of 35% on the estimated excess consumption, reflecting the possible profit of the assessee. Ultimately, the Tax Appeals were dismissed, affirming the decisions of the lower authorities.

---